$11.1M
sold in all offerings
BioGene Therapeutics Inc. is a corporation based in Austin, TX in the Biotechnology industry group. From July 23, 2026 to August 7, 2026 it filed 5 private fundraising filings for 5 offerings and reported $11.1 million sold in all.
Updated October 10, 2026 · newest filing Aug 7, 2026
Amount sold
$11.1M
All offerings, newest filing of each
Offered
$11.1M
Total amount sought
Offerings
5
5 filings with amendments
Newest offering
$3.0M
Sold, first filed Aug 7, 2026
Investors
1
In the newest offering
Min. investment
-
In the newest offering
Facts
- Type
- Corporation
- Place
- Austin, TX
- Industry group
- Biotechnology
- Listed
- No
- First filing
- July 23, 2026
- Newest filing
- August 7, 2026
- Exemptions
- 506(b)
Offerings
5 offerings, newest first, each at its newest filing
| First filed | Amount sold | Offered | Investors | Min. investment | Exemptions | Securities |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | $3.0M | $3.0M | 1 | - | 506(b) | Options or warrants, Securities on exercise of options |
| Aug 6, 2026 | $3.0M | $3.0M | 1 | - | 506(b) | Options or warrants, Securities on exercise of options |
| Aug 6, 2026 | $250K | $250K | 1 | - | 506(b) | Options or warrants, Securities on exercise of options |
| Aug 6, 2026 | $250K | $250K | 1 | - | 506(b) | Options or warrants, Securities on exercise of options |
| Jul 23, 2026 | $4.5M | $4.5M | 6 | - | 506(b) | Options or warrants, Securities on exercise of options |
Filing history
5 filings, newest first. An amendment updates an earlier offering.
| Filed | Kind | Amount sold | Offered | Investors |
|---|---|---|---|---|
| Aug 7, 2026 | New offering | $3.0M | $3.0M | 1 |
| Aug 6, 2026 | New offering | $3.0M | $3.0M | 1 |
| Aug 6, 2026 | New offering | $250K | $250K | 1 |
| Aug 6, 2026 | New offering | $250K | $250K | 1 |
| Jul 23, 2026 | New offering | $4.5M | $4.5M | 6 |
Related pages
Questions and answers
How much has BioGene Therapeutics Inc. raised in private offerings?
$11.1 million sold in 5 private offerings reported from Jul 23, 2026 to Aug 7, 2026, counting each offering once at its newest filing.
When did BioGene Therapeutics Inc. last file about a private offering?
August 7, 2026. Its newest offering reported $3 million sold of $3 million offered to 1 investor.
Which exemption does BioGene Therapeutics Inc. use?
506(b). Rule 506(b) does not allow public advertising.
Is BioGene Therapeutics Inc. a listed company?
No ticker is linked to this issuer, so it is private or no longer listed.
These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.